Chapter 20 Somatostatin
- 1 January 1979
- book chapter
- Published by Elsevier
- Vol. 14, 209-218
- https://doi.org/10.1016/s0065-7743(08)61365-2
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Hyperglucagonemia and Its SuppressionNew England Journal of Medicine, 1978
- A Follow-up Study of Vascular Disease in Growth-Hormone-Deficient Dwarfs with DiabetesNew England Journal of Medicine, 1978
- The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cellsLife Sciences, 1977
- Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitusDiabetologia, 1977
- Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analogBiochemical and Biophysical Research Communications, 1977
- Hypothesis: Physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitusLife Sciences, 1977
- A bicyclo-somatostatin analog, highly specific for the inhibition of growth hormone releaseBiochemical and Biophysical Research Communications, 1977
- Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in ratsLife Sciences, 1976
- Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of Langerhans and isolated hepatocytesBiochemical and Biophysical Research Communications, 1975
- Acylated des-[Ala1-Gly2]-somatostatin analogs: Prolonged inhibition of growth hormone secretionBiochemical and Biophysical Research Communications, 1974